About Robert Thompson
Form D filings for Amorphex Therapeutics Holdings in 2023 list Robert Thompson as chief executive officer and director.
Robert Thompson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Thompson in the role, so the role may have started earlier or lasted longer.